| Literature DB >> 33449232 |
Laura Vearrier1, Carrie M Henderson2.
Abstract
This paper introduces the model of Utilitarian Principlism as a framework for crisis healthcare ethics. In modern Western medicine, during non-crisis times, principlism provides the four guiding principles in biomedical ethics-autonomy, nonmaleficence, beneficence, and justice; autonomy typically emerges as the decisive principle. The physician-patient relationship is a deontological construct in which the physician's primary duty is to the individual patient and the individual patient is paramount. For this reason, we term the non-crisis ethical framework that guides modern medicine Deontological Principlism. During times of crisis, resources become scarce, standards of care become dynamic, and public health ethics move to the forefront. Healthcare providers are forced to work in non-ideal conditions, and interactions with individual patients must be considered in the context of the crisis. The COVID-19 pandemic has forced healthcare to shift to a more utilitarian framework with a greater focus on promoting the health of communities and populations. This paper puts forth the notion of Utilitarian Principlism as a framework for crisis healthcare ethics. We discuss each of the four principles from a utilitarian perspective and use clinical vignettes, based on real cases from the COVID-19 pandemic, for illustrative purposes. We explore how Deontological Principlism and Utilitarian Principlism are two ends of a spectrum, and the implications to healthcare as we emerge from the pandemic.Entities:
Keywords: Bioethics; COVID-19; Pandemics; Population health; Principlism; Standard of care
Mesh:
Year: 2021 PMID: 33449232 PMCID: PMC7809094 DOI: 10.1007/s10730-020-09431-7
Source DB: PubMed Journal: HEC Forum ISSN: 0956-2737
Communicable diseases for which isolation and quarantine are authorized (Centers for Disease Control and Prevention 2020a)
| Cholera |
| Diphtheria |
| Infectious tuberculosis |
| Plague |
| Smallpox |
| Yellow fever |
| Viral hemorrhagic fever |
| Severe acute respiratory syndromes |
| Flu that can cause a pandemic |
Clinical trial testing
| Medications | Devices |
|---|---|
| 1. Safety & toxicity | 1. Pilot/feasibility |
| 2. Safety & efficacy | 2. Pivotal/confirmatory |
| 3. Clinical effectiveness relative to standard therapy |
Factors thought to be driving increased COVID-19 incidence in inner city minority communities
| Inability to socially distance |
| Reliance on public transportation |
| Crowded housing conditions |
| Availability and affordability of face masks |
| Inability to self-isolate |
| Homelessness |
| Availability and affordability of delivered essential items |
| Work-related issues |
| Service-industry or front-facing jobs |
| Inability to work remotely or from home |
| Essential industry jobs |
| Co-morbidities associated with more severe infection (greater infectivity) |
| Diabetes mellitus |
| Hypertension |
| Obesity |